References
- Shaw J. B., Chandrasekaran S. K. Controlled topical delivery of drugs for systemic action. Drug Metab. Rev. 1978; 8: 223
- Alfredsan L. S., Norell S. E. Spacing between doses in a thrice daily regimen. Br. Med. J. 1981; 282: 1036
- DeHaan P., Lerk C. L. Oral controlled release dosage forms: A review. Pharmacol. Week bl. (Sci. Ed.) 1984; 6: 57
- Goldstein D. A., Tan Y. K., Soldin S. J. Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. Eur. J. Clin. Pharmacol. 1987; 36: 631
- British Pharmacopoeia. Ministry of Health and Social Sciences for Northern Ireland 1980; 11: A-53
- Shigbal D. M., Joshi S. V. Spectrocolorimetric Estimation of salbutamol sulphate and its pharmaceutical formulations. Indian Drugs 1984; 21: 398
- Sanvordekar D. R., Cooney J. G., Wester R. C. Transdermal nitroglycerine pad. U.S. Patent No.4, June 22, 1982, 336, 243
- Iyer B. V., Vasavada R. C. Evaluation of lanolin alcohol film and kinetics of triancinolone acetomide release. J. Pharm. Sci. 1979; 68: 783
- Walker S. R., Evans M. E., Richardson A. J., Paterson J. W. The clinical pharmacology of oral and inhaled salbutamol. Clin. Pharmacol. Therp. 1972; 13: 861
- Hutchings M. J., Pault J. D., Morgan D. J. Determination of salbutamol in plasma by high performance liquid chromatography with fluorescence detection. J. Chromatogr. 1983; 277: 423